Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Allen

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2008
Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient miceGuy L Odom, Paul Gregorevic, James M Allen, et al.
Human Molecular Genetics|June 26, 2007
Functional capacity of dystrophins carrying deletions in the N-terminal actin-binding domainGlen B Banks, Paul Gregorevic, James M Allen, et al.
Pain|April 1, 1995
The lack of hypoalgesic efficacy of H-wave therapy on experimental ischaemic painBrona C McDowell, Andrea S Lowe, Deirdre M Walsh, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 19, 2007
Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failureDeWayne Townsend, Michael J Blankinship, James M Allen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 25, 2009
Physiotherapy management of cancer-related fatigue: a survey of UK current practiceCaroline M Donnelly, Andrea Lowe-Strong, Jane P Rankin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 6, 2019
Development of Novel Micro-dystrophins with Enhanced FunctionalityJulian N Ramos, Katrin Hollinger, Niclas E Bengtsson, et al.
Journal of Virology|May 16, 2008
Biodistribution and safety profile of recombinant adeno-associated virus serotype 6 vectors following intravenous deliveryDaniel Stone, Ying Liu, Zong-Yi Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2006
Foamy virus vector integration sites in normal human cellsGrant D Trobridge, Daniel G Miller, Michael A Jacobs, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 12, 2007
Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppressionZejing Wang, Christian S Kuhr, James M Allen, et al.
Human Gene Therapy|December 21, 2006
Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophyZejing Wang, James M Allen, Stanley R Riddell, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2008
Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient miceGuy L Odom, Paul Gregorevic, James M Allen, et al.
Human Molecular Genetics|June 26, 2007
Functional capacity of dystrophins carrying deletions in the N-terminal actin-binding domainGlen B Banks, Paul Gregorevic, James M Allen, et al.
Pain|April 1, 1995
The lack of hypoalgesic efficacy of H-wave therapy on experimental ischaemic painBrona C McDowell, Andrea S Lowe, Deirdre M Walsh, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 19, 2007
Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failureDeWayne Townsend, Michael J Blankinship, James M Allen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 25, 2009
Physiotherapy management of cancer-related fatigue: a survey of UK current practiceCaroline M Donnelly, Andrea Lowe-Strong, Jane P Rankin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 6, 2019
Development of Novel Micro-dystrophins with Enhanced FunctionalityJulian N Ramos, Katrin Hollinger, Niclas E Bengtsson, et al.
Journal of Virology|May 16, 2008
Biodistribution and safety profile of recombinant adeno-associated virus serotype 6 vectors following intravenous deliveryDaniel Stone, Ying Liu, Zong-Yi Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2006
Foamy virus vector integration sites in normal human cellsGrant D Trobridge, Daniel G Miller, Michael A Jacobs, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 12, 2007
Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppressionZejing Wang, Christian S Kuhr, James M Allen, et al.
Human Gene Therapy|December 21, 2006
Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophyZejing Wang, James M Allen, Stanley R Riddell, et al.
Pageof 4